Selvam Rajajee, Jarrar Amer, Meghaizel Cynthia, Mamazza Joseph, Neville Amy, Walsh Caolan, Kolozsvari Nicole
Division of General Surgery, Department of Surgery, The Ottawa Hospital, Civic Campus, Loeb Research Building, 725 Parkdale Avenue - Office WM150B, Ottawa, ON, K1Y 4E9, Canada.
Surg Endosc. 2023 Jan;37(1):364-370. doi: 10.1007/s00464-022-09518-x. Epub 2022 Aug 11.
A quality improvement opportunity was identified to de-adopt the low-value care practice of routinely performing bloodwork for all patients undergoing elective bariatric surgery. While these patients are typically discharged on postoperative day 1 (POD1) after bloodwork is performed, it is uncommon for the discharge plan to change due to unexpected laboratory abnormalities alone.
Patients undergoing bariatric surgery between September 2020 and April 2021 only had POD1 bloodwork if there were perioperative clinical concerns, they had insulin-dependent diabetes, or they were therapeutically anticoagulated. Thirty-day Emergency Department (ED) visits and readmissions were monitored as balancing measures. Outcomes were compared to a control group that underwent bariatric surgery prior to September 2020 when POD1 laboratory testing was routinely performed. Financial and environmental costs were estimated based our institutional standards.
The intervention group consisted of 303 patients: 248 (82%) Roux-en-Y gastric bypasses and 55 (18%) sleeve gastrectomies. Most patients (n = 256, 84.5%) did not have POD1 bloodwork. Twelve (3.9%) had bloodwork performed in violation of our protocol, of which none had a change in management based on the results. Of the 35 (12%) who had appropriately ordered bloodwork, 6 (2%) required a transfusion and 2 (0.7%) required a second surgery on the same admission for hemorrhage. Forty-four (14.5%) had 30-day ED visits of which 17 (5.6%) were within 7 days. Sixteen (5.3%) were readmitted. There were no significant differences between intervention and control groups in the rate of transfusion, second surgery, or 30-day ED visits. The avoidance of POD1 bloodwork saved approximately $6602.24 in lab processing fees alone and 512 test tubes.
POD1 bloodwork can be safely avoided in the absence of clinical concerns. In addition to not significantly increasing postoperative complications, there were benefits from a financial cost, environmental impact, and patient discomfort perspective.
发现了一个质量改进机会,即不再采用为所有接受择期减肥手术的患者常规进行血液检查这种低价值医疗行为。虽然这些患者通常在进行血液检查后的术后第1天(POD1)出院,但仅因意外的实验室异常而改变出院计划的情况并不常见。
2020年9月至2021年4月期间接受减肥手术的患者,只有在围手术期存在临床问题、患有胰岛素依赖型糖尿病或接受治疗性抗凝的情况下才在POD1进行血液检查。将30天内的急诊科(ED)就诊和再入院情况作为平衡指标进行监测。将结果与2020年9月之前接受减肥手术的对照组进行比较,当时常规进行POD1实验室检查。根据我们机构的标准估算财务和环境成本。
干预组由303名患者组成:248例(82%)接受Roux-en-Y胃旁路手术,55例(18%)接受袖状胃切除术。大多数患者(n = 256,84.5%)未在POD1进行血液检查。12例(3.9%)违反我们的方案进行了血液检查,其中没有一例根据检查结果改变治疗方案。在35例(12%)已适当安排血液检查的患者中,6例(2%)需要输血,2例(0.7%)因出血在同一次住院期间需要进行二次手术。44例(14.5%)有30天内的ED就诊,其中17例(5.6%)在7天内。16例(5.3%)再次入院。干预组和对照组在输血率、二次手术率或30天内ED就诊率方面没有显著差异。仅避免POD1血液检查就节省了约6602.24美元的实验室处理费用和512个试管。
在没有临床问题的情况下,可以安全地避免在POD1进行血液检查。除了不会显著增加术后并发症外,从财务成本、环境影响和患者不适的角度来看还有益处。